241 related articles for article (PubMed ID: 10941138)
1. Piperazine analog of vesamicol: in vitro and in vivo characterization for vesicular acetylcholine transporter.
Bando K; Naganuma T; Taguchi K; Ginoza Y; Tanaka Y; Koike K; Takatoku K
Synapse; 2000 Oct; 38(1):27-37. PubMed ID: 10941138
[TBL] [Abstract][Full Text] [Related]
2. [18F]fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses.
Mulholland GK; Wieland DM; Kilbourn MR; Frey KA; Sherman PS; Carey JE; Kuhl DE
Synapse; 1998 Nov; 30(3):263-74. PubMed ID: 9776130
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel 4- and 5-substituted benzyl ether derivatives of vesamicol and in vitro evaluation of their binding properties to the vesicular acetylcholine transporter site.
Scheunemann M; Sorger D; Wenzel B; Heinitz K; Schliebs R; Klingner M; Sabri O; Steinbach J
Bioorg Med Chem; 2004 Mar; 12(6):1459-65. PubMed ID: 15018919
[TBL] [Abstract][Full Text] [Related]
4. Acetylcholine binding site in the vesicular acetylcholine transporter.
Ojeda AM; Kolmakova NG; Parsons SM
Biochemistry; 2004 Sep; 43(35):11163-74. PubMed ID: 15366926
[TBL] [Abstract][Full Text] [Related]
5. Dissociation of the vesicular acetylcholine transporter domains important for high-affinity transport recognition, binding of vesamicol and targeting to synaptic vesicles.
Varoqui H; Erickson JD
J Physiol Paris; 1998 Apr; 92(2):141-4. PubMed ID: 9782458
[TBL] [Abstract][Full Text] [Related]
6. Hydroxylated decahydroquinolines as ligands for the vesicular acetylcholine transporter: synthesis and biological evaluation.
Efange SM; Khare AB; Mach RH; Parsons SM
J Med Chem; 1999 Jul; 42(15):2862-9. PubMed ID: 10425095
[TBL] [Abstract][Full Text] [Related]
7. Analysis of uptake and release of newly synthesized acetylcholine in PC12 cells overexpressing the rat vesicular acetylcholine transporter (VAChT).
Roghani A; Carroll PT
Brain Res Mol Brain Res; 2002 Apr; 100(1-2):21-30. PubMed ID: 12008018
[TBL] [Abstract][Full Text] [Related]
8. N-hydroxyalkyl derivatives of 3 beta-phenyltropane and 1-methylspiro[1H-indoline-3,4'-piperidine]: vesamicol analogues with affinity for monoamine transporters.
Efange SM; Kamath AP; Khare AB; Kung MP; Mach RH; Parsons SM
J Med Chem; 1997 Nov; 40(24):3905-14. PubMed ID: 9397171
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and binding affinities of methylvesamicol analogs for the acetylcholine transporter and sigma receptor.
Shiba K; Ogawa K; Ishiwata K; Yajima K; Mori H
Bioorg Med Chem; 2006 Apr; 14(8):2620-6. PubMed ID: 16434200
[TBL] [Abstract][Full Text] [Related]
10. Vesamicol receptor mapping of brain cholinergic neurons with radioiodine-labeled positional isomers of benzovesamicol.
Jung YW; Frey KA; Mulholland GK; del Rosario R; Sherman PS; Raffel DM; Van Dort ME; Kuhl DE; Gildersleeve DL; Wieland DM
J Med Chem; 1996 Aug; 39(17):3331-42. PubMed ID: 8765517
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of radiolabeled piperazine derivatives of vesamicol as SPECT agents for cholinergic neurons.
Bando K; Taguchi K; Ginoza Y; Naganuma T; Tanaka Y; Koike K; Takatoku K
Nucl Med Biol; 2001 Apr; 28(3):251-60. PubMed ID: 11323234
[TBL] [Abstract][Full Text] [Related]
12. Vesamicol and some of its derivatives: questionable ligands for selectively labelling acetylcholine transporters in rat brain.
Custers FG; Leysen JE; Stoof JC; Herscheid JD
Eur J Pharmacol; 1997 Nov; 338(2):177-83. PubMed ID: 9456000
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological characterization of stable and radioiodinated (+/-)-trans-2-hydroxy-3-P[4-(3-iodophenyl)piperidyl]-1,2,3,4-tetrahydronaphthalene (3'-IBVM).
Efange SM; von Hohenberg K ; Khare AB; Tu Z; Mach RH; Parsons SM
Nucl Med Biol; 2000 Nov; 27(8):749-55. PubMed ID: 11150707
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.
Goodman MM; Chen P; Plisson C; Martarello L; Galt J; Votaw JR; Kilts CD; Malveaux G; Camp VM; Shi B; Ely TD; Howell L; McConathy J; Nemeroff CB
J Med Chem; 2003 Mar; 46(6):925-35. PubMed ID: 12620070
[TBL] [Abstract][Full Text] [Related]
15. [3H]vesamicol binding in brain: autoradiographic distribution, pharmacology, and effects of cholinergic lesions.
Altar CA; Marien MR
Synapse; 1988; 2(5):486-93. PubMed ID: 2973145
[TBL] [Abstract][Full Text] [Related]
16. The pharmacology of vesamicol: an inhibitor of the vesicular acetylcholine transporter.
Prior C; Marshall IG; Parsons SM
Gen Pharmacol; 1992 Nov; 23(6):1017-22. PubMed ID: 1487110
[TBL] [Abstract][Full Text] [Related]
17. Binding characteristics of 9-fluoropropyl-(+)-dihydrotetrabenzazine (AV-133) to the vesicular monoamine transporter type 2 in rats.
Tsao HH; Lin KJ; Juang JH; Skovronsky DM; Yen TC; Wey SP; Kung MP
Nucl Med Biol; 2010 May; 37(4):413-9. PubMed ID: 20447551
[TBL] [Abstract][Full Text] [Related]
18. Kinetic parameters for the vesicular acetylcholine transporter: two protons are exchanged for one acetylcholine.
Nguyen ML; Cox GD; Parsons SM
Biochemistry; 1998 Sep; 37(38):13400-10. PubMed ID: 9748347
[TBL] [Abstract][Full Text] [Related]
19. Selective in vitro and in vivo binding of [(125)I]ADAM to serotonin transporters in rat brain.
Choi SR; Hou C; Oya S; Mu M; Kung MP; Siciliano M; Acton PD; Kung HF
Synapse; 2000 Dec; 38(4):403-12. PubMed ID: 11044887
[TBL] [Abstract][Full Text] [Related]
20. Structural changes of benzylether derivatives of vesamicol and their influence on the binding selectivity to the vesicular acetylcholine transporter.
Wenzel B; Sorger D; Heinitz K; Scheunemann M; Schliebs R; Steinbach J; Sabri O
Eur J Med Chem; 2005 Dec; 40(12):1197-205. PubMed ID: 16095762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
